HUNTINGTONS-DISEASE AND DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY - PROTEINS, PATHOGENESIS AND PATHOLOGY

Citation
Ca. Ross et al., HUNTINGTONS-DISEASE AND DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY - PROTEINS, PATHOGENESIS AND PATHOLOGY, Brain pathology, 7(3), 1997, pp. 1003-1016
Citations number
137
Categorie Soggetti
Pathology,Neurosciences,"Clinical Neurology
Journal title
ISSN journal
10156305
Volume
7
Issue
3
Year of publication
1997
Pages
1003 - 1016
Database
ISI
SICI code
1015-6305(1997)7:3<1003:HADA-P>2.0.ZU;2-J
Abstract
Each of the glutamine repeat neurodegenerative diseases has a particul ar pattern of pathology largely restricted to the CNS, However, there is considerable overlap among the regions affected, suggesting that th e diseases share pathogenic mechanisms, presumably involving the gluta mine repeats, We focus on Huntington's disease (HD) and Dentatorubral- pallidoluysian atrophy (DRPLA) as models for this family of diseases, since they have striking similarities and also notable differences in their clinical features and pathology,, We review the pattern of patho logy in adult and juvenile onset cases, Despite selective pathology, t he disease genes and their protein products (huntingtin and atrophin-1 ) are widely expressed, This presents a central problem for all the gl utamine repeat diseases - how do widely expressed gene products give r ise to restricted pathology? The pathogenic effects are believed to oc cur via a ''gain of function'' mechanism at the protein level, Mechani sms of cell death may include excitotoxicity, metabolic toxicity, apop tosis, and free radical stress. Emerging data indicate that huntingtin and atrophin-1 may have distinct protein interactions, The specific i nteraction partners may help explain the selective pathology of these diseases.